Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evido is a digital health company dedicated to transforming metabolic health through personalized, data-driven interventions. The company's platform integrates continuous glucose monitoring (CGM) data with artificial intelligence to provide real-time, actionable insights for individuals managing conditions like type 2 diabetes and obesity. By focusing on the intersection of nutrition, lifestyle, and metabolic biology, Evido aims to help users achieve sustainable weight loss and improved glycemic control. Their approach emphasizes precision health, tailoring recommendations to each user's unique physiological responses to food and activity. Evido partners with healthcare providers and employers to deliver scalable metabolic care solutions that improve clinical outcomes and reduce long-term healthcare costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evido.